Table 2.
Fatty acid | REGb | CLA+VAc | p |
10:0 | 0.17 ± 0.05 | 0.12 ± 0.03 | 0.08 |
12:0 | 0.67 ± 0.44 | 0.54 ± 0.13 | 0.52 |
14:0 | 1.36 ± 0.31 | 1.03 ± 0.12 | 0.04* |
14:1 | 0.32 ± 0.04 | 0.28 ± 0.05 | 0.18 |
16:0 | 20.1 ± 0.90 | 17.1 ± 0.75 | <0.01* |
16:1 | 1.02 ± 0.17 | 0.89 ± 0.13 | 0.16 |
18:0 | 16.3 ± 1.6 | 14.6 ± 0.9 | 0.054 |
18:1 9c | 16.2 ± 1.7 | 16.2 ± 0.3 | 0.98 |
18:2 n-6 | 20.0 ± 1.3 | 21.6 ± 2.4 | 0.20 |
18:3 n-3 | 0.81 ± 0.13 | 1.02 ± 0.09 | 0.01* |
18:1 t11 | 0.27 ± 0.05 | 1.09 ± 0.18 | <0.01* |
c9,t11-CLA | 0.28 ± 0.08 | 0.80 ± 0.07 | <0.01* |
20:4 n-6 | 8.2 ± 1.0 | 8.1 ± 0.4 | 0.89 |
20:5 n-3 | 1.49 ± 0.19 | 1.46 ± 0.06 | 0.65 |
22:5 n-3 | 1.41 ± 0.15 | 1.47 ± 0.19 | 0.57 |
22:6 n-3 | 1.74 ± 0.34 | 1.46 ± 0.17 | 0.10 |
aValues given as mean ± SD, and p-values, n = 6.
bDiet containing regular butter as fat supplement
cDiet containing CLA+VA rich butter as fat supplement
* p < 0.05.